Skip to content

Vir Biotechnology, Inc.

n0n

Ransomware leak-site victim intelligence

Posted
Nov 16, 2026
Country
US
Industry
Healthcare

What was taken

biopharmaceutical (chronic hepatitis infections) · United States | Hepatitis D and hepatitis B testing and treatment claims for a US biopharmaceutical company's franchise: 113,235,341 patient level rows covering 7,144,993 distinct patients, with ages, birth years, payer details and provider identities; Prescription claims for the company's hepatitis D product with patient identifiers, prescriber NPI numbers and payer details | [NOT PAID — EXPOSED]